FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1303123006: Product containing only dapagliflozin and saxagliptin (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5304845017 Product containing only dapagliflozin and saxagliptin (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5304846016 Dapagliflozin and saxagliptin only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5304845017 Product containing only dapagliflozin and saxagliptin (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5304846016 Dapagliflozin and saxagliptin only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only dapagliflozin and saxagliptin (medicinal product) Is a Dapagliflozin- and saxagliptin-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only dapagliflozin and saxagliptin (medicinal product) Plays role Antidiabetic therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only dapagliflozin and saxagliptin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Saxagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only dapagliflozin and saxagliptin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dapagliflozin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Dapagliflozin and saxagliptin only product in oral dose form Is a True Product containing only dapagliflozin and saxagliptin (medicinal product) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start